432. Argentina supports the request submitted by Bangladesh and Uganda on behalf of the LDCs, contained in document IP/C/W/605.
433. We believe that an extension of the transitional period under Article 66.1 for LDC Members with respect to pharmaceutical products and for waivers from the obligations of Articles 70.8 and 70.9 would give LDC Members the flexibility, policy space and time they need to address serious and urgent public health issues relating to communicable and non communicable diseases and access to medicines.